BIOMAT Database Logo BIOMAT Database Logo

[Mechanisms of tumoral resistance to antineoplastic agents]. 1994

A L Albiero, and D H Pozzi
Disciplina de Hematologia e Hemoterapia da Faculdade de Medicina da Universidade de São Paulo.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

A L Albiero, and D H Pozzi
[Multifactor resistance to various antineoplastic agents].
January 1989, Bulletin du cancer,
A L Albiero, and D H Pozzi
[Testing of tumor resistance to antineoplastic agents].
March 1968, Nordisk medicin,
A L Albiero, and D H Pozzi
[Resistance to antineoplastic treatments: mechanisms, clinical value].
January 1996, Comptes rendus des seances de la Societe de biologie et de ses filiales,
A L Albiero, and D H Pozzi
Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization.
September 2012, Cancer immunology, immunotherapy : CII,
A L Albiero, and D H Pozzi
Mechanisms of resistance to alkylating agents.
September 1998, Cytotechnology,
A L Albiero, and D H Pozzi
MECHANISMS OF RESISTANCE TO ANTICANCER AGENTS.
January 1963, Advances in cancer research,
A L Albiero, and D H Pozzi
Mechanisms of resistance to alkylating agents.
January 1994, Cancer treatment and research,
A L Albiero, and D H Pozzi
[Mechanisms of resistance to antifungal agents].
February 2007, Nihon rinsho. Japanese journal of clinical medicine,
A L Albiero, and D H Pozzi
Mechanisms of resistance to alkylating agents.
January 1996, Cancer treatment and research,
A L Albiero, and D H Pozzi
[Mechanism of action and resistance of antineoplastic agents].
November 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!